Life Science Reit Plc (GB:LABS)
LSE:LABS
Holding GB:LABS?
Track your performance easily

Life Science Reit Plc (LABS) Financial Statements

0 Followers

Life Science Reit Plc Financial Overview

Life Science Reit Plc's market cap is currently ―. The company's EPS TTM is p-0.114; its P/E ratio is -3.88; and it has a dividend yield of 2.38%. Life Science Reit Plc is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22
Income Statement-
Total Revenue--
Ebit--
Ebitda--
Net Income Common Stockholders--
Balance Sheet-
Total Assets£ 447.82M£ 483.10M
Total Debt£ 109.83M£ 96.86M
Net Debt£ -319.45M£ -357.46M
Total Liabilities£ 128.37M£ 125.64M
Stockholders Equity£ 319.45M£ 357.46M
Cash Flow-
Free Cash Flow--
Operating Cash Flow--
Investing Cash Flow--
Financing Cash Flow--
Currency in GBP

Life Science Reit Plc Earnings and Revenue History

Life Science Reit Plc Debt to Assets

Life Science Reit Plc Cash Flow

Life Science Reit Plc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis